ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CEL Celadon Pharmaceuticals Plc

61.00
1.50 (2.52%)
22 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Celadon Pharmaceuticals Plc LSE:CEL London Ordinary Share GB00BDQYGP38 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  1.50 2.52% 61.00 57.00 65.00 61.00 59.50 59.50 12,246 14:00:11
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Investment Advice 149k -7.14M -0.1082 -5.64 39.26M

Holding(s) in Company

20/12/2007 4:57pm

UK Regulatory


RNS Number:4362K
Celsis International PLC
20 December 2007


                                                                    

TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES


(1). Identity of the issuer or the underlying issuer of existing shares to which
voting rights are attached:

Celsis International Plc


2. Reason for the notification (please state Yes/No): (   )

An acquisition or disposal of voting rights:                               (Yes)

An acquisition or disposal of financial instruments which may result 
in the acquisition of shares already issued to which voting rights are 
attached:                                                                  ( No)

An event changing the breakdown of voting rights:                          ( No)

Other (please specify) :                                                   (   )


 
3. Full name of person(s) subject to the notification obligation:

Loeb Partners Corporation 
 

4. Full name of shareholder(s) (if different from 3.):

(as above)
 

5. Date of the transaction and date on which the threshold is crossed or reached
if different):

19 December 2007
 

6. Date on which issuer notified:

20 December 2007
 

7. Threshold(s) that is/are crossed or reached:

3%
 

8. Notified details:


 


A: Voting rights attached to shares

 
Class/type of shares            Situation previous to  
if possible using the           the Triggering         
ISIN CODE                       transaction        
                       Number of shares       Number of voting Rights 

GB00B0CD5F69            607,500                    607,500

 

                     Resulting situation after the triggering transaction 
 
Class/type of shares Number of shares  Number of voting rights    % of voting rights  
if possible using                                                                 
the ISIN CODE                                                                         
                     Direct            Direct     Indirect        Direct    Indirect  

GB00B0CD5F69        757,500           757,500      -             3.43%
 

B: Financial Instruments

Resulting situation after the triggering transaction 

Type of     Expiration Date  Exercise/Conversion Number of voting     % of voting     
financial                    Period/ Date        rights that may be   rights          
instrument                                       acquired if the                      
                                                 instrument is                        
                                                 exercised/                           
                                                 converted.                           

   N/A

Total (A+B)
Number of voting rights       % of voting rights 

757,500                            3.43%
 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:

N/A
 


Proxy Voting:

 
10. Name of the proxy holder:

N/A
 

11. Number of voting rights proxy holder will cease to hold:


 

12. Date on which proxy holder will cease to hold voting rights:


 

13. Additional information:


 

14. Contact name:

Michael Emanuel
 

15. Contact telephone number:

+1 212 483 7047


 





                      This information is provided by RNS
            The company news service from the London Stock Exchange

END

HOLURONRBNRUUAA

1 Year Celadon Pharmaceuticals Chart

1 Year Celadon Pharmaceuticals Chart

1 Month Celadon Pharmaceuticals Chart

1 Month Celadon Pharmaceuticals Chart

Your Recent History

Delayed Upgrade Clock